In an interview with Nature, Dr. Collins discusses progress of AMP and major milestones to speed drug discovery
Launched in 2014, the Accelerating Medicines Partnership is an effort to speed the development of therapies for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease. Nature: Online: February 27, 2019.
This page last reviewed on